Reserpine and Hydrochlorothiazide Tablets
»Reserpine and Hydrochlorothiazide Tablets contain not less than 90.0percent and not more than 110.0percent of the labeled amount of reserpine (C33H40N2O9),and not less than 93.0percent and not more than 107.0percent of the labeled amount of hydrochlorothiazide (C7H8ClN3O4S2).
Packaging and storage— Preserve in tight,light-resistant containers.
Identification—
A: Transfer a quantity of powdered Tablets,equivalent to 1mg of reserpine,to a stoppered,50-mLcentrifuge tube.Add 20mLof citric acid solution (1in 50),and shake until the powder is suspended.Extract the mixture with two 20-mLportions of chloroform,centrifuge,and withdraw the chloroform,filtering each extract through a pledget of cotton into a 50-mLvolumetric flask.Dilute with chloroform to volume,and mix:the UVabsorption spectrum of the solution exhibits maxima and minima at the same wavelengths as that of a similar solution of USP Reserpine RS,concomitantly measured (presence of reserpine).
B: Transfer a quantity of powdered Tablets,equivalent to about 50mg of hydrochlorothiazide,to a test tube containing 10mLof acetone,agitate for 5minutes,and centrifuge.Use the clear supernatant as the Test solution.Separately apply 10µLeach of the Test solution and a Standard solution of USP Hydrochlorothiazide RSin acetone containing 5mg per mLto a thin-layer chromatographic plate (see Chromatography á621ñ)coated with a 0.25-mm layer of chromatographic silica gel mixture and previously washed with methanol.Develop the chromatogram in a solvent system consisting of a mixture of ethyl acetate and isopropyl alcohol (17:3)until the solvent front has moved about three-fourths of the length of the plate.Remove the plate from the chamber,air-dry,and examine under short-wavelength UVlight:the RFvalue of the principal spot in the chromatogram of the Test solution corresponds to that obtained from the Standard solution (presence of hydrochlorothiazide).
Dissolution á711ñ
Medium: mixture of 0.1Nhydrochloric acid and n-propyl alcohol (3:2);900mL.
Apparatus 2: 50rpm.
Times: 45minutes,60minutes.
Determination of dissolved reserpine—
PHOSPHATEBUFFER Dissolve 6.8g of monobasic potassium phosphate in 1liter of water,mix thoroughly,and adjust with phosphoric acid to a pHof 3.0±0.05.
MOBILEPHASE Prepare a filtered and degassed mixture ofPhosphate buffer and acetonitrile (65:35).Make adjustments if necessary (seeSystem Suitability underChromatography á621ñ).
STANDARDSTOCK PREPARATION Dissolve an accurately weighed quantity of USP Reserpine RSinMedium,and dilute quantitatively and stepwise if necessary,withMedium to obtain a solution having a known concentration of about 0.14µg per mL.
STANDARDPREPARATION Transfer 8.0mLofStandard stock preparation to a 25-mLvolumetric flask.Dilute withMobile phase to volume,and mix to obtain a solution having a known concentration of about 0.044µg per mL.
TESTPREPARATION Filter a portion of the solution under test,and transfer 8.0mLto a 25-mLvolumetric flask.Dilute withMobile phase to volume,and mix.
CHROMATOGRAPHICSYSTEM(see Chromatography á621ñ)— The liquid chromatograph is equipped with a fluorescence detector (excitation at 270nm and detection at 360nm)and a 4.6-mm ×15-cm column that contains packing L11.The flow rate is about 2.0mLper minute.Chromatograph theStandard preparation,and record the peak responses as directed forProcedure:the capacity factor,k¢,is not less than 2.0;the column efficiency is not less than 3000theoretical plates;the tailing factor is not more than 2.0;and the relative standard deviation for replicate injections is not more than 2.0%.
PROCEDURE Separately inject equal volumes (about 100µL)of theStandard preparation and theAssay preparation into the chromatograph,record the chromatograms,and measure the responses for the reserpine peak.Calculate the quantity,in mg,of reserpine (C33H40N2O9)dissolved by the formula:
2813C(rU/rS),
in whichCis the concentration,in mg per mL,of USP Reserpine RSin theStandard preparation;andrUandrSare the peak responses obtained from theTest preparation and theStandard preparation,respectively.
Determination of dissolved hydrochlorothiazide—
STANDARDPREPARATION Dissolve about 27mg of USP Hydrochlorothiazide RS,accurately weighed,in a 50-mLvolumetric flask containing 5mLof methanol,dilute withDissolution Medium to volume,and mix.Pipet 2mLof this solution into a 100-mLvolumetric flask,dilute withDissolution Medium to volume,and mix.
PROCEDURE Determine the amount of hydrochlorothiazide (C7H8ClN3O4S2)dissolved from UVabsorption,at the wavelength of maximum absorbance at about 271nm,on filtered portions of the solution under test,suitably diluted withDissolution Medium,in comparison with theStandard preparation.
Tolerances— Not less than 80%(Q)of the labeled amount of C33H40N2O9is dissolved in 45minutes and not less than 80%(Q)of the labeled amount of C7H8ClN3O4S2is dissolved in 60minutes.
Uniformity of dosage units á905ñ: meet the requirements with respect to reserpine and to hydrochlorothiazide.
Procedure for content uniformity for reserpine—
STANDARDPREPARATION Prepare as directed forStandard preparationunderAssay for reserpine.
TESTSOLUTION Weigh 1Tablet,grind to a fine powder,and transfer to a stoppered,50-mLcentrifuge tube.Add 25.0mLof a mixture of chloroform and methanol solution (1:1),shake by mechanical means for 15minutes,and centrifuge.Pipet 4mLof the clear supernatant into a 100-mLvolumetric flask,dilute with the chloroform-methanol solution to volume,and mix.
PROCEDURE Proceed as directed forProcedureunderAssay for reserpine.Calculate the quantity,in mg,of C33H40N2O9,in the Tablet taken by the formula:
(Wt/WU)(TC/D)(IU/IS),
in whichWtis the weight,in mg,of the Tablet;WUis the weight,in mg,in the portion of Tablet taken;Tis the labeled quantity,in mg,of reserpine in the Tablet;Cis the concentration,in µg per mL,of USP Reserpine RSin theStandard preparation;Dis the concentration,in µg per mL,of reserpine in theTest solution,based upon the labeled quantity per Tablet and the extent of dilution;andIUandISare the fluorescence intensities of the solutions from theTest solutionand theStandard preparation,respectively.
Procedure for content uniformity for hydrochlorothiazide—
STANDARDPREPARATION Prepare as directed forStandard preparationunderAssay for hydrochlorothiazide.
TESTSOLUTION Transfer 1Tablet to a 250-mLvolumetric flask,add 150mLof 0.1Nsodium hydroxide,and sonicate,swirling the flask intermittently,until the tablet is dissolved.Dilute with 0.1Nsodium hydroxide to volume,mix,and filter,discarding the first 15mLof the filtrate.Dilute a portion of the clear filtrate quantitatively and stepwise with 0.1Nsodium hydroxide to obtain a solution having a concentration of about 10µg of hydrochlorothiazide per mL.
PROCEDURE Proceed as directed forProcedureunderAssay for hydrochlorothiazide.Calculate the quantity,in mg,of C7H8ClN3O4S2,in the Tablet taken by the formula:
(TC/D)(AU/AS),
in whichTis the labeled quantity,in mg,of hydrochlorothiazide in the Tablet;Cis the concentration,in µg per mL,of USP Hydrochlorothiazide RSin theStandard preparation;Dis the concentration,in µg per mL,of hydrochlorothiazide in theTest solution,based upon the labeled quantity per Tablet and the extent of dilution;andAUandASare the absorbances of the solutions from theTest solutionand theStandard preparation,respectively.
Diazotizable substances—
Standard solution— Accurately weigh 25mg of USP Benzothiadiazine Related Compound A RS,dissolve in 5mLof methanol contained in a 100-mLvolumetric flask,dilute with water to volume,and mix.Pipet 4mLof this solution into a 100-mLvolumetric flask,dilute with water to volume,and mix.
Test solution— Transfer a portion of finely powdered Tablets,accurately weighed and equivalent to about 100mg of hydrochlorothiazide,to a 100-mLvolumetric flask,and add 20mLof methanol and 20mLof water.Shake continuously for 5to 10minutes,dilute with water to volume,mix,and filter.Use the filtrate as theTest solution.
Procedure— Pipet 5mLeach of theStandard solutionand theTest solutioninto separate,50-mLvolumetric flasks.Pipet 5mLof water into a third 50-mLvolumetric flask to provide the blank.To each flask add 1mLof freshly prepared sodium nitrite solution (1in 100)and 5mLof dilute hydrochloric acid (1in 12),and allow to stand for 5minutes.Add 2mLof ammonium sulfamate solution (1in 50),shake vigorously,allow to stand for 5minutes,then add 2mLof freshly prepared disodium chromotropate solution (1in 100)and 10mLof sodium acetate TS.Dilute with water to volume,and mix.Concomitantly determine the absorbances of the solutions from theStandard solutionand theTest solutionin 1-cm cells at the wavelength of maximum absorbance at about 500nm,with a suitable spectrophotometer,against the blank.The absorbance of the solution from theTest solutiondoes not exceed that of the solution from theStandard solution,corresponding to not more than 1.0%of diazotizable substances.
Assay for reserpine—
Standard preparation— Dissolve about 25mg of USP Reserpine RS,accurately weighed,in 1mLof chloroform contained in a 50-mLvolumetric flask,dilute with methanol to volume,and mix.Dilute a portion of this solution quantitatively and stepwise with chloroform and methanol solution (1:1)to obtain a solution having a known concentration of about 0.2µg of reserpine per mL.
Assay preparation— Weigh and finely powder not fewer than 20Tablets.Transfer to a stoppered,50-mLcentrifuge tube an accurately weighed portion of the powder,equivalent to about 1mg of reserpine,add 25.0mLof a mixture of chloroform and methanol solution (1:1),shake by mechanical means for 15minutes,and centrifuge.Dilute a portion of the clear supernatant quantitatively and stepwise with a mixture of chloroform and methanol solution (1:1)to obtain a solution having a concentration of about 0.2µg of reserpine per mL.
Procedure— Separately transfer 5.0mLof the Assay preparation,5.0mLof the Standard preparation,and 5.0mLof a mixture of chloroform and methanol solution (1:1)to provide the reagent blank,respectively,to three 25-mLvolumetric flasks.To each flask add 0.5mLof hydrochloric acid,1.0mLof a 3in 1000solution of sodium nitrite in dilute methanol (1in 2),mix,and allow to stand for 30minutes.Add 1mLof ammonium sulfamate solution (1in 20)to each flask,add chloroform and methanol solution (1:1)to volume,mix,and allow to stand for 10minutes.Concomitantly determine the fluorescence intensities of the solutions in a suitable spectrophotometer arranged to deliver activation radiation at 405nm and to measure the resultant fluorescence at the emission wavelength of about 500nm.Calculate the quantity,in mg,of C33H40N2O9in the portion of Tablets taken by the formula:
5C(IU/IS),
in which Cis the concentration,in µg per mL,of USP Reserpine RSin the Standard preparation,and IUand ISare the fluorescence intensities of the solutions from the Assay preparationand the Standard preparation,respectively.
Assay for hydrochlorothiazide—
Standard preparation— Dissolve an accurately weighed quantity of USP Hydrochlorothiazide RSin 0.1Nsodium hydroxide,and dilute quantitatively and stepwise with 0.1Nsodium hydroxide to obtain a solution having a known concentration of about 10µg of hydrochlorothiazide per mL.Use a freshly prepared solution.
Assay preparation— Weigh and finely powder not fewer than 20Tablets.Weigh accurately a portion of the powder,equivalent to about 50mg of hydrochlorothiazide,and transfer to a 500-mLvolumetric flask.Add 200mLof 0.1Nsodium hydroxide,shake by mechanical means for 15minutes,dilute with the same solvent to volume,and mix.Filter a portion of the solution through paper,discarding the first 15mLof the filtrate,and transfer 10.0mLof the clear filtrate to a 100-mLvolumetric flask.Dilute with 0.1Nsodium hydroxide to volume,and mix.
Procedure— Concomitantly determine the absorbances of the Standard preparationand the Assay preparationin 1-cm cells at the wavelength of maximum absorbance,at about 274nm,with a suitable spectrophotometer,using 0.1Nsodium hydroxide as the blank.Calculate the quantity,in mg,of C7H8ClN3O4S2in the portion of Tablets taken by the formula:
5C(AU/AS),
in which Cis the concentration,in µg per mL,of USP Hydrochlorothiazide RSin the Standard preparation,and AUand ASare the absorbances of the solutions from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Andrzej Wilk,Ph.D.,Senior Scientific Associate
Expert Committee:(PA5)Pharmaceutical Analysis 5
USP28–NF23Page 1718
Pharmacopeial Forum:Volume No.28(6)Page 1749
Phone Number:1-301-816-8305